自噬
六烯酸
神经保护
细胞生物学
ULK1
β淀粉样蛋白
乙酰半胱氨酸
药理学
生物
化学
生物化学
安普克
细胞凋亡
抗氧化剂
脂肪酸
多不饱和脂肪酸
蛋白激酶A
肽
磷酸化
作者
Xiaoxu Wang,Yu Song,Peixu Cong,Zhigao Wang,Yanjun Liu,Jie Xu,Changhu Xue
标识
DOI:10.1002/mnfr.202300414
摘要
SCOPE: Astaxanthin (AST) is ubiquitous in aquatic foods and microorganisms. The study previously finds that docosahexaenoic acid-acylated AST monoester (AST-DHA) improves cognitive function in Alzheimer's disease (AD), although the underlying mechanism remains unclear. Moreover, autophagy is reportedly involved in amyloid-β (Aβ) clearance and AD pathogenesis. Therefore, this study aims to evaluate the preventive effect of AST-DHA and elucidates the mechanism of autophagy modulation in Aβ pathology. METHODS AND RESULTS: cells. In APP/PS1 mice, a 3-month dietary supplementation of AST-DHA exceeded free-astaxanthin (F-AST) capacity to increase hippocampal and cortical autophagy. Mechanistically, AST-DHA restores autophagy by activating the ULK1 signaling pathway and restoring autophagy-lysosome fusion. Moreover, AST-DHA relieves ROS production and mitochondrial stress affecting autophagy in AD. As a favorable outcome of restored autophagy, AST-DHA mitigates cerebral Aβ and p-Tau deposition, ultimately improving neuronal function. CONCLUSION: The findings demonstrate that AST-DHA can rectify autophagic impairment in AD, and confer neuroprotection in Aβ-related pathology, which supports the future application of AST as an autophagic inducer for maintaining brain health.
科研通智能强力驱动
Strongly Powered by AbleSci AI